X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44806) 44806
Book Chapter (100) 100
Conference Proceeding (31) 31
Publication (22) 22
Dissertation (20) 20
Magazine Article (13) 13
Government Document (3) 3
Book / eBook (2) 2
Book Review (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (41705) 41705
mice (39903) 39903
3t3 cells (25465) 25465
humans (20006) 20006
nih 3t3 cells (14689) 14689
biochemistry & molecular biology (13175) 13175
cell biology (9597) 9597
cell line (7298) 7298
molecular sequence data (7044) 7044
transfection (6834) 6834
expression (6163) 6163
phosphorylation (5920) 5920
cells (5537) 5537
rats (5092) 5092
base sequence (4853) 4853
amino acid sequence (4803) 4803
cells, cultured (4746) 4746
signal transduction (4621) 4621
oncology (4277) 4277
proteins (3784) 3784
female (3487) 3487
activation (3439) 3439
male (3400) 3400
research (3312) 3312
gene expression (3258) 3258
protein binding (3179) 3179
protein (3162) 3162
hela cells (3113) 3113
fibroblasts (3060) 3060
cell line, tumor (2944) 2944
multidisciplinary sciences (2791) 2791
tumor cells, cultured (2700) 2700
kinetics (2620) 2620
cancer (2588) 2588
apoptosis (2499) 2499
mutation (2460) 2460
mice, inbred balb c (2384) 2384
gene expression regulation (2378) 2378
research article (2366) 2366
biophysics (2332) 2332
differentiation (2326) 2326
gene (2323) 2323
analysis (2316) 2316
genetics & heredity (2305) 2305
cell lines (2281) 2281
fibroblasts - metabolism (2277) 2277
transcription, genetic (2246) 2246
promoter regions, genetic (2229) 2229
time factors (2226) 2226
gene-expression (2225) 2225
dna (2207) 2207
binding sites (2177) 2177
materials science, biomaterials (2136) 2136
cell proliferation (2116) 2116
rna, messenger - metabolism (2110) 2110
in-vitro (2095) 2095
growth (2079) 2079
identification (2071) 2071
binding (2032) 2032
blotting, western (2019) 2019
transcription factors - metabolism (1954) 1954
cell survival - drug effects (1941) 1941
enzyme activation (1909) 1909
cloning, molecular (1905) 1905
dna-binding proteins - metabolism (1863) 1863
swiss 3t3 cells (1852) 1852
dose-response relationship, drug (1850) 1850
mice, inbred c57bl (1836) 1836
cell cycle (1825) 1825
rna, messenger - genetics (1824) 1824
cos cells (1800) 1800
physiological aspects (1781) 1781
pharmacology & pharmacy (1775) 1775
cell differentiation (1773) 1773
cell adhesion (1767) 1767
engineering, biomedical (1763) 1763
cell division (1747) 1747
fibroblasts - cytology (1740) 1740
recombinant fusion proteins - metabolism (1739) 1739
in-vivo (1697) 1697
cell division - drug effects (1614) 1614
cell nucleus - metabolism (1598) 1598
cell growth (1556) 1556
recombinant proteins - metabolism (1556) 1556
genes (1542) 1542
proliferation (1527) 1527
transcription (1491) 1491
receptor (1474) 1474
transcription factors - genetics (1451) 1451
cell transformation, neoplastic (1445) 1445
fibroblasts - drug effects (1425) 1425
cricetinae (1408) 1408
enzyme inhibitors - pharmacology (1405) 1405
protein structure, tertiary (1405) 1405
cell proliferation - drug effects (1390) 1390
inhibition (1350) 1350
transcriptional activation (1329) 1329
dna-binding proteins - genetics (1312) 1312
endocrinology & metabolism (1311) 1311
hek293 cells (1307) 1307
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44626) 44626
Chinese (399) 399
Japanese (318) 318
Russian (128) 128
German (30) 30
French (14) 14
Korean (7) 7
Polish (5) 5
Portuguese (5) 5
Spanish (5) 5
Italian (3) 3
Hungarian (2) 2
Ukrainian (2) 2
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | APOPTOSIS | ANTIINFLAMMATORY ACTIVITY | CELL-CYCLE ARREST | PROLIFERATION | FLUOROURACIL | CANCER | IN-VITRO | ONCOLOGY | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | EA.hy 926 endothelial cells | INHIBITORS | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2012, Volume 109, Issue 20, pp. 7630 - 7635
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2016, Volume 113, Issue 3, pp. E291 - E299
Protein transduction domains (PTDs) are powerful nongenetic tools that allow intracellular delivery of conjugated cargoes to modify cell behavior... 
Human embryonic stem cells | Transduction | Cell-penetrating peptides | Differentiation | Heparin-binding domain | differentiation | transduction | MULTIDISCIPLINARY SCIENCES | MECHANISMS | HEPARIN | MAMMALIAN-CELLS | IPS CELLS | PLURIPOTENT STEM-CELLS | cell-penetrating peptides | heparin-binding domain | MACROPINOCYTOSIS | GROWTH-FACTOR | PROTEINS | human embryonic stem cells | NIH 3T3 Cells | Homeodomain Proteins - metabolism | Human Embryonic Stem Cells - cytology | Humans | Mouse Embryonic Stem Cells - cytology | Mouse Embryonic Stem Cells - drug effects | Mouse Embryonic Stem Cells - metabolism | Drug Delivery Systems | Nanoparticles | Human Embryonic Stem Cells - drug effects | Integrases - metabolism | Cell Membrane - metabolism | Cell Membrane - drug effects | Cell-Penetrating Peptides - chemistry | Induced Pluripotent Stem Cells - metabolism | Protein Structure, Tertiary | Detergents - pharmacology | Human Embryonic Stem Cells - metabolism | Nanog Homeobox Protein | Induced Pluripotent Stem Cells - drug effects | Glycosaminoglycans - metabolism | Endocytosis - drug effects | Solubility | MyoD Protein - metabolism | Nucleic Acids - metabolism | Trypsin - metabolism | Amino Acid Motifs | Animals | Muscle Development - drug effects | Cell Differentiation - drug effects | Cell Proliferation - drug effects | Mice | Genome | Cell-Penetrating Peptides - metabolism | Physiological aspects | Physiological research | Cellular signal transduction | Glycosaminoglycans | Research | Biological Sciences | PNAS Plus
Journal Article
Tissue engineering. Part C, Methods, ISSN 1937-3392, 2011, Volume 17, Issue 5, pp. 537 - 548
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2003, Volume 100, Issue 20, pp. 11457 - 11462
Journal Article
Journal Article
STEM CELLS, ISSN 1066-5099, 03/2018, Volume 36, Issue 3, pp. 337 - 348
.... The transparent corneal epithelium is regenerated by limbal stem cells (LSCs), whose loss/dysfunction results in LSCs deficiency (LSCD... 
Human induced pluripotent stem cell | Human embryonic stem cell | Corneal epithelial cells | Bone morphogenetic protein 4 | Epidermal growth factor | Corneal epithelial progenitors | Retinoic acid | DEFINED FACTORS | ORAL MUCOSAL EPITHELIUM | INDUCTION | DEFICIENCY | OCULAR SURFACE RECONSTRUCTION | TRANSPLANTATION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | IN-VITRO | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SMAD | HEMATOLOGY | PRECURSORS | EXPRESSION | Cell Line | Epithelium, Corneal - cytology | Humans | Lymphotoxin-alpha - metabolism | Cell Differentiation - genetics | Bone Morphogenetic Proteins - metabolism | Animals | Cell Differentiation - drug effects | Fluorescent Antibody Technique | Dioxoles - pharmacology | Epithelium, Corneal - metabolism | Benzamides - pharmacology | Mice | Induced Pluripotent Stem Cells - cytology | Bone Morphogenetic Proteins - genetics | Real-Time Polymerase Chain Reaction | 3T3 Cells | Lymphotoxin-alpha - antagonists & inhibitors | Induced Pluripotent Stem Cells - metabolism | Bone morphogenetic proteins | Cell differentiation | Embryonic stem cells | Collagen | Tretinoin | Autografts | Cornea | Epithelial cells | Embryo cells | Transforming growth factor-a | Retina | Transplantation | Epithelium | Embryos | Eye | Signal transduction | Signaling | Stem cells | Media (differential) | Eye (anatomy) | Damage | Differentiation | Growth factors | Pluripotency | Vision Loss | Embryonic Stem Cells | Repair | Induced Pluripotent Stem Cells
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2014, Volume 4, Issue 1, p. 4012
Journal Article